{
    "clinical_study": {
        "@rank": "33590", 
        "acronym": "Trigger-open", 
        "arm_group": [
            {
                "arm_group_label": "Bupivacaine", 
                "arm_group_type": "Experimental", 
                "description": "injection, 25 mg, once, 5 min"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "injection, 10 ml 0.9% sodium chloride, once, 5 min"
            }
        ], 
        "brief_summary": {
            "textblock": "Groin hernia repair is a common procedure performed in approximately 2,000 patients per one\n      million inhabitants. Severe chronic pain following groin hernia repair is seen in 2-5% of\n      the patients indicating that a large number of patients each year suffer from debilitating\n      reduction in health-related quality of life.\n\n      This study examines the effect of ultra-sound guided blocks with local anesthesia in the\n      groin in regard to pain relief and sleep quality.\n\n      The hypothesis of the study is that a block will confer significant pain relief to patients\n      with severe chronic pain following open groin hernia repair."
        }, 
        "brief_title": "Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Inguinal Hernia", 
            "Chronic Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hernia", 
                "Hernia, Inguinal"
            ]
        }, 
        "detailed_description": {
            "textblock": "This placebo-controlled, randomized, double-blind, cross-over study in subjects with severe\n      pain after open groin hernia, examines the effect of an ultra-sound guided local anesthetic\n      block of a trigger-point, situated near the spermatic cord at the superficial inguinal ring.\n      In order to compare effects and distribution of the blocks in patients vs. healthy subjects,\n      the block is tested and examined in volunteers using a similar methodology."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with persistent pain (< 6 mo) after open groin hernia repair\n\n          -  Patients with maximal pain area 3 cm or less from the superficial inguinal ring\n\n          -  Patients living in the Capital Region of Denmark (Region Hovedstaden) or the Region\n             of Zealand (Region Sj\u00e6lland)\n\n        Exclusion Criteria:\n\n          -  Known allergy to bupivacaine or other local anesthetics of amide-type\n\n          -  Declared incapable of making his/hers own affairs\n\n          -  Does not comprehend Danish in the written or spoken language\n\n          -  Cognitive impairment to a degree influencing the testing reliability\n\n          -  Known recurrence of the  inguinal hernia\n\n          -  Other surgical procedures performed in the groin or on the external genitals\n\n          -  Neuropathy affecting the groin region caused by other conditions, e.g. post-stroke,\n             multiple sclerosis, herniated intervertebral disc\n\n          -  Abuse of alcohol or drugs\n\n          -  Unable to cooperate with the sensory examinations"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065219", 
            "org_study_id": "H-3-2011-130-open", 
            "secondary_id": "2612-1006"
        }, 
        "intervention": {
            "arm_group_label": "Bupivacaine", 
            "description": "10 ml of bupivacaine 2.5 mg/ml deposited  by ultra-sound guidance around the spermatic cord", 
            "intervention_name": "Bupivacaine", 
            "intervention_type": "Drug", 
            "other_name": "Bupivacain \"SAD\""
        }, 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic Pain", 
            "Inguinal Hernia", 
            "Outcome", 
            "Surgical Procedure, Operative"
        ], 
        "lastchanged_date": "February 14, 2014", 
        "location": {
            "contact": {
                "email": "mads.u.werner@gmail.com", 
                "last_name": "Mads Werner", 
                "phone": "28257703"
            }, 
            "contact_backup": {
                "email": "nelun.wijayasinghe@regionh.dk", 
                "last_name": "Nelun Wijayasinghe, MD", 
                "phone": "+4535457618"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Multidisciplinary Pain Center, Neuroscience Center, Copenhagen University Hospital, DENMARK"
            }, 
            "investigator": [
                {
                    "last_name": "Nelun Wijayasinghe, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Thomas K Ringsted, RN", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Joakim M Bischoff, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Mads U. Werner, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair", 
        "overall_contact": {
            "email": "mads.u.werner@gmail.com", 
            "last_name": "Mads U. Werner, MD", 
            "phone": "+4528257703"
        }, 
        "overall_official": [
            {
                "affiliation": "Multidisciplinary Pain Center, Neuroscience Center, Rigshospitalet, Copenhagen University Hospital, DENMARK", 
                "last_name": "Mads U Werner, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Section of Surgical Pathophysiology, Juliane Marie Center, Copenhagen University Hospital, DENMARK", 
                "last_name": "Henrik Kehlet, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The number of patients with normalized summed pain intensity differences (SPID) of more or equal to 50% after bupivacaine AND SPID less or equal to 25% after placebo.", 
            "measure": "Normalized summed pain intensity difference (SPID)", 
            "safety_issue": "No", 
            "time_frame": "20 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065219"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "mads u werner", 
            "investigator_title": "MD, MDSc", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Quantitative changes in thermal thresholds (warmth detection threshold, cool detection thresholds, heat pain threshold) after bupivacaine compared to placebo", 
                "measure": "Thermal thresholds", 
                "safety_issue": "Yes", 
                "time_frame": "20 min"
            }, 
            {
                "description": "Quantitative changes in pain ratings to suprathreshold heat stimulation after bupivacaine compared to placebo", 
                "measure": "Suprathreshold heat stimulation", 
                "safety_issue": "No", 
                "time_frame": "20 min"
            }, 
            {
                "description": "Quantitative changes in pain rating to pressure algometry stimulation after bupivacaine compared to placebo", 
                "measure": "Pressure pain thresholds", 
                "safety_issue": "Yes", 
                "time_frame": "20 min"
            }, 
            {
                "description": "Quantitative changes in area of cool hypoesthesia assessed by a thermal roller after bupivacaine compared to placebo", 
                "measure": "Sensory mapping", 
                "safety_issue": "No", 
                "time_frame": "20 min"
            }, 
            {
                "description": "Quantitative changes in summed pain intensity differences (SPIDs) during rest, movement and during auto-palpation, assessed morning and evening after bupivacaine compared to placebo", 
                "measure": "Pain questionnaire", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "Quantitative changes in sleep quality assessed each morning, after bupivacaine compared to placebo", 
                "measure": "Sleep quality", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}